Trial Profile
Exploring the Role of Prostaglandin D2 and the DP1 Receptor on Nicotinic Acid Induced Flushing.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Niacin (Primary) ; Aspirin
- Indications Dyslipidaemias; Myocardial infarction; Pain; Rheumatic disorders; Stroke; Thrombosis
- Focus Pharmacodynamics
- 11 Mar 2010 Actual number of patients added to 30 as reported by ClinicalTrials.gov.
- 11 Mar 2010 Actual end date added to 1 Feb 2010 as reported by ClinicalTrials.gov.
- 11 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.